iHope Genetic Health partners with clinical sites, including hospitals, clinics and universities, and advocacy organizations worldwide to facilitate clinician-ordered clinical genome and exome sequencing for individuals with childhood-onset suspected genetic disease who remain undiagnosed and lack access to testing.
Our current network of clinical sites include 17 partners in the United States (6), Peru (3), Mexico (2), Botswana (1) Croatia (1), Ghana (1), North Macedonia (1), the United Arab Emirates (1), and Zimbabwe (1). More than 2,600 individuals with suspected genetic disease and their families have received genome and exome sequencing tests through iHope to-date.
We welcome inquiries from clinicians and institutions interested in partnering with iHope to expand access to genomic sequencing for underserved children with rare diseases. Although an active award cycle is not currently open, we encourage you to complete our Clinical Site Application. Submissions will continue to be reviewed on a rolling basis for consideration in a future application cycle.
Open May 23, 2025- Close June 20, 2025: Awardees have been notified. Public notification forthcoming.